Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

AXSM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,822,513.12

Axsome Therapeutics Insider Trading History Chart

Axsome Therapeutics Share Price & Price History

^$71.17

▼ -1.91 (-2.61%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Get the full story here.

Axsome Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Mark L. Jacobson	COO	Sell	24,662	$77.24	$1,904,892.88
3/14/2024	Roger Jeffs	Director	Sell	29,976	$69.70	$2,089,327.20	120,756
9/15/2023	Mark Coleman	Director	Sell	11,016	$75.19	$828,293.04	25,097
11/19/2021	Roger Jeffs	Director	Buy	3,950	$37.30	$147,335.00
11/18/2021	Nick Pizzie	CFO	Buy	527	$35.50	$18,708.50
11/17/2021	Mark E. Saad	Director	Buy	3,000	$34.53	$103,590.00
5/12/2021	Mark Coleman	Director	Buy	500	$58.15	$29,075.00

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

Get the full story here.

SEC Filings (Institutional Ownership Changes) for Axsome Therapeutics (NASDAQ:AXSM)

81.49% of Axsome Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Axsome Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Wesbanco Bank Inc.	8,300	$0.66M	0.0%	N/A	0.018%
4/23/2024	Raymond James Financial Services Advisors Inc.	17,321	$1.38M	0.0%	-4.5%	0.037%
4/17/2024	Hennion & Walsh Asset Management Inc.	69,483	$5.55M	0.3%	+14.6%	0.147%
4/15/2024	Janiczek Wealth Management LLC	1,213	$97K	0.0%	N/A	0.003%
4/10/2024	Yarbrough Capital LLC	5,054	$0.40M	0.0%	N/A	0.011%
3/11/2024	Vanguard Group Inc.	3,696,766	$294.23M	0.0%	-0.9%	7.804%
3/5/2024	Wellington Management Group LLP	239,819	$19.09M	0.0%	+1.0%	0.506%
2/26/2024	Perceptive Advisors LLC	1,038,019	$82.62M	1.9%	+115.5%	2.194%
2/22/2024	Sierra Summit Advisors LLC	9,224	$0.73M	0.2%	N/A	0.019%
2/15/2024	PFM Health Sciences LP	467,427	$37.20M	2.2%	-10.7%	0.988%
2/15/2024	Great Point Partners LLC	4,963	$0.40M	0.1%	N/A	0.010%
2/15/2024	BVF Inc. IL	1,981,100	$157.68M	4.0%	-7.0%	4.187%
2/14/2024	Point72 Asset Management L.P.	837,201	$66.63M	0.2%	+57.4%	1.769%
2/14/2024	Avidity Partners Management LP	459,400	$36.56M	1.3%	+54.8%	0.971%
2/14/2024	Superstring Capital Management LP	16,179	$1.29M	0.9%	N/A	0.034%
2/14/2024	Bellevue Group AG	635,372	$50.57M	0.8%	+0.6%	1.343%
2/14/2024	Lighthouse Investment Partners LLC	56,202	$4.47M	0.2%	N/A	0.119%
2/13/2024	Affinity Asset Advisors LLC	50,000	$3.98M	0.7%	N/A	0.106%
2/13/2024	CIBC Private Wealth Group LLC	17,999	$1.43M	0.0%	+0.8%	0.038%
2/13/2024	Rhenman & Partners Asset Management AB	79,100	$6.30M	0.6%	+97.3%	0.167%
2/12/2024	TD Asset Management Inc	16,000	$1.27M	0.0%	N/A	0.034%
2/12/2024	Hsbc Holdings PLC	80,437	$6.37M	0.0%	-45.9%	0.170%
2/9/2024	US Bancorp DE	143,424	$11.42M	0.0%	+3.4%	0.303%
2/9/2024	Aigen Investment Management LP	3,866	$0.31M	0.1%	N/A	0.008%
2/9/2024	D.A. Davidson & CO.	7,240	$0.58M	0.0%	-2.6%	0.015%
2/9/2024	Norges Bank	195,123	$15.53M	0.0%	N/A	0.412%
2/8/2024	Meridian Wealth Management LLC	20,498	$1.63M	0.1%	+6.6%	0.043%
2/8/2024	Janney Montgomery Scott LLC	5,280	$0.42M	0.0%	-5.0%	0.011%
2/8/2024	Nicholas Investment Partners LP	82,645	$6.58M	0.8%	-79.1%	0.175%
2/8/2024	First Turn Management LLC	295,428	$23.51M	3.4%	N/A	0.624%
2/7/2024	Principal Financial Group Inc.	9,497	$0.76M	0.0%	+1.3%	0.020%
2/7/2024	Jump Financial LLC	8,400	$0.67M	0.0%	N/A	0.018%
2/7/2024	Dana Investment Advisors Inc.	13,641	$1.09M	0.1%	-3.6%	0.029%
2/7/2024	BNP Paribas Financial Markets	19,477	$1.55M	0.0%	-27.2%	0.041%
2/7/2024	Teacher Retirement System of Texas	7,188	$0.57M	0.0%	-22.4%	0.015%
2/6/2024	Charles Schwab Investment Management Inc.	295,701	$23.54M	0.0%	+2.0%	0.625%
2/6/2024	National Bank of Canada FI	600	$46K	0.0%	-99.0%	0.001%
2/6/2024	Amalgamated Bank	5,090	$0.41M	0.0%	-2.7%	0.011%
2/6/2024	Swiss National Bank	60,500	$4.82M	0.0%	-15.6%	0.128%
2/5/2024	Victory Capital Management Inc.	5,208	$0.42M	0.0%	-72.5%	0.011%
2/5/2024	Cannell & Co.	82,845	$6.59M	0.2%	-20.5%	0.175%
2/5/2024	AtonRa Partners	4,678	$0.37M	0.7%	-9.7%	0.010%
2/5/2024	Intrust Bank NA	2,846	$0.23M	0.0%	-11.0%	0.006%
2/2/2024	Truist Financial Corp	21,086	$1.68M	0.0%	N/A	0.045%
2/2/2024	State of New Jersey Common Pension Fund D	38,049	$3.03M	0.0%	+17.2%	0.080%
2/1/2024	New York State Common Retirement Fund	28,047	$2.23M	0.0%	+12.2%	0.059%
2/1/2024	Handelsbanken Fonder AB	7,700	$0.61M	0.0%	+13.2%	0.016%
2/1/2024	CWM LLC	38,371	$3.05M	0.0%	-4.4%	0.081%
2/1/2024	Lindbrook Capital LLC	84,086	$6.69M	0.7%	-0.3%	0.178%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,834	$0.46M	0.0%	-24.5%	0.012%
1/30/2024	Strs Ohio	6,000	$0.48M	0.0%	-36.8%	0.013%
1/30/2024	Phocas Financial Corp.	26,890	$2.14M	0.3%	N/A	0.057%
1/29/2024	WCM Investment Management LLC	104,808	$8.35M	0.0%	+9.2%	0.221%
1/26/2024	Mutual of America Capital Management LLC	34,578	$2.75M	0.0%	-4.4%	0.073%
1/26/2024	Iridian Asset Management LLC CT	138,337	$11.01M	2.0%	-4.6%	0.292%
1/26/2024	Peregrine Capital Management LLC	84,817	$6.75M	0.2%	-6.9%	0.179%
1/26/2024	Moody Aldrich Partners LLC	66,866	$5.32M	1.0%	-9.2%	0.141%
1/24/2024	Arizona State Retirement System	8,575	$0.68M	0.0%	-7.6%	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	5,475	$0.44M	0.1%	+354.7%	0.012%
1/23/2024	DAVENPORT & Co LLC	3,817	$0.30M	0.0%	N/A	0.008%
1/18/2024	Washington Trust Advisors Inc.	330	$26K	0.0%	N/A	0.001%
1/16/2024	Oak Ridge Investments LLC	15,517	$1.24M	0.1%	-14.0%	0.033%
1/16/2024	Raymond James Financial Services Advisors Inc.	18,136	$1.44M	0.0%	-3.2%	0.038%
1/12/2024	SG Americas Securities LLC	2,141	$0.17M	0.0%	N/A	0.005%
1/8/2024	Baldwin Brothers LLC MA	48,995	$3.90M	0.3%	+2.1%	0.104%
12/18/2023	Vanguard Group Inc.	3,729,126	$260.63M	0.0%	-0.4%	7.881%
12/1/2023	Wellington Management Group LLP	237,554	$16.60M	0.0%	+18.9%	0.502%
11/30/2023	Neo Ivy Capital Management	2,912	$0.20M	0.1%	N/A	0.006%
11/22/2023	Graham Capital Management L.P.	13,255	$0.93M	0.0%	N/A	0.028%
11/17/2023	OLD National Bancorp IN	4,550	$0.32M	0.0%	-44.9%	0.010%
11/15/2023	Dana Investment Advisors Inc.	14,148	$0.99M	0.1%	-19.7%	0.030%
11/15/2023	Alethea Capital Management LLC	758,794	$53.03M	65.1%	-0.2%	1.604%
11/15/2023	RTW Investments LP	4,489,596	$313.78M	6.6%	+4.8%	9.488%
11/15/2023	Kennedy Capital Management LLC	12,092	$0.85M	0.0%	+24.2%	0.026%
11/15/2023	Adage Capital Partners GP L.L.C.	325,000	$22.71M	0.1%	-26.9%	0.687%
11/15/2023	Alps Advisors Inc.	34,828	$2.43M	0.0%	+8.7%	0.074%
11/15/2023	Glenmede Trust Co. NA	8,203	$0.57M	0.0%	+96.6%	0.017%
11/14/2023	Eventide Asset Management LLC	346,712	$24.23M	0.4%	N/A	0.733%
11/14/2023	Schonfeld Strategic Advisors LLC	67,698	$4.73M	0.0%	-10.1%	0.143%
11/14/2023	Avidity Partners Management LP	296,800	$20.74M	0.8%	-45.5%	0.627%
11/14/2023	Trexquant Investment LP	17,450	$1.22M	0.0%	N/A	0.037%
11/14/2023	Profund Advisors LLC	8,133	$0.57M	0.0%	-8.0%	0.017%
11/13/2023	Northern Trust Corp	349,057	$24.40M	0.0%	+7.0%	0.738%
11/13/2023	Hsbc Holdings PLC	148,812	$10.43M	0.0%	N/A	0.314%
11/13/2023	Pearl River Capital LLC	9,935	$0.69M	0.1%	-39.4%	0.021%
11/13/2023	FMR LLC	1,858,556	$129.89M	0.0%	-12.7%	3.928%
11/13/2023	Rafferty Asset Management LLC	4,560	$0.32M	0.0%	+4.7%	0.010%
11/13/2023	Kestra Advisory Services LLC	7,896	$0.55M	0.0%	-16.8%	0.017%
11/13/2023	Atika Capital Management LLC	71,000	$4.96M	0.7%	-36.6%	0.150%
11/13/2023	PNC Financial Services Group Inc.	5,351	$0.37M	0.0%	-3.2%	0.011%
11/13/2023	Maven Securities LTD	7,500	$0.52M	0.0%	-78.6%	0.016%
11/9/2023	Rhumbline Advisers	50,845	$3.55M	0.0%	+8.9%	0.108%
11/9/2023	Tocqueville Asset Management L.P.	6,200	$0.43M	0.0%	-13.9%	0.013%
11/9/2023	Deutsche Bank AG	60,046	$4.20M	0.0%	+4.2%	0.127%
11/9/2023	Blair William & Co. IL	12,270	$0.86M	0.0%	+3.4%	0.026%
11/9/2023	Mutual of America Capital Management LLC	36,168	$2.53M	0.0%	-5.6%	0.077%
11/9/2023	UBS Group AG	32,784	$2.29M	0.0%	+124.9%	0.069%
11/8/2023	State Board of Administration of Florida Retirement System	10,042	$0.70M	0.0%	+7.5%	0.021%
11/8/2023	Charles Schwab Investment Management Inc.	289,871	$20.26M	0.0%	+8.0%	0.614%
11/8/2023	Janney Montgomery Scott LLC	5,560	$0.39M	0.0%	+23.9%	0.012%

Data available starting January 2016

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Today's Range

Now: $71.17

$69.92

$73.14

50 Day Range

MA: $76.15

$65.72

$93.46

52 Week Range

Now: $71.17

$55.02

$98.40

Volume

583,558 shs

Average Volume

727,474 shs

Market Capitalization

$3.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of Axsome Therapeutics?: Axsome Therapeutics' top insider investors include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark L Jacobson (COO)
Learn More about top insider investors at Axsome Therapeutics.
Who are the major institutional investors of Axsome Therapeutics?: Axsome Therapeutics' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.15%
Raymond James Financial Services Advisors Inc. — 0.04%
Wesbanco Bank Inc. — 0.02%
Yarbrough Capital LLC — 0.01%
Janiczek Wealth Management LLC — 0.00%
Learn More about top institutional investors of Axsome Therapeutics stock.
Which institutional investors are selling Axsome Therapeutics stock?: During the last quarter, AXSM stock was sold by these institutional investors:
Raymond James Financial Services Advisors Inc.
During the last year, company insiders that have sold Axsome Therapeutics company stock include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark L Jacobson (COO)
Learn More investors selling Axsome Therapeutics stock.
Which institutional investors are buying Axsome Therapeutics stock?: Within the previous quarter, AXSM stock was bought by institutional investors including:
Hennion & Walsh Asset Management Inc.
Wesbanco Bank Inc.
Yarbrough Capital LLC
Janiczek Wealth Management LLC